ASCO has updated its guidelines on the use of systemic therapy for advanced hepatocellular carcinoma.
Researchers found that greater exposure to nitrogen dioxide is associated with an increased risk of uterine cancer.
Primary treatment modifications can improve tolerability without compromising efficacy in older patients with advanced cancer, new data suggest.
Patients who reported moderate use of multivitamins after a colorectal cancer diagnosis had a lower risk of cancer-specific death and all-cause death.
Liso-cel is cost-effective as second-line therapy for diffuse large B-cell lymphoma, according to researchers.
Many US physicians do not have a solid understanding of the FDA’s processes for drug approval or medical device approval, a survey suggests.
Continuous use of low-dose aspirin is associated with an increased risk of certain cancers and a decreased risk of other cancers, data suggest.
A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.
A meta-analysis suggests that delaying chemotherapy in patients with asymptomatic, advanced cancer does not worsen overall survival.
Atezolizumab, given with or without radiotherapy, has demonstrated some activity in a subset of patients with penile cancer.
